On the wake of demands raising for beds and medicines for COVID-19 patients. On Saturday DCGI gave a good news to the nation. DCGI announced a new drug. Which could be created in large quantity in small time. The name of the drug 2-deoxy-D-glucose (2-DG) . This drug is created by DRDO personals with a private company Dr. Reddy’s.
DCGI has granted permission for emergency use of therapeutic application of drug 2-deoxy-D-glucose (2-DG) as adjunct therapy in moderate to severe COVID-19 patients. Being a generic molecule & analogue of glucose, it can be easily produced & made available in plenty: DRDO .
The drug has been developed by DRDO lab Institute of Nuclear Medicine & Allied Sciences in collaboration with Dr Reddy’s Laboratories. Clinical trial have shown that this molecule helps in faster recovery of hospitalized patients & reduces supplemental oxygen dependence: DRDO.
The drug comes in the form of a powder packed in a sachets. The drug is usually dissolved in water and after stirring it may ingested orally. The 2-DG drug has been proved to be a boon whose oxygen rates may drop. In the treatment it was found that the 2-DG drug was seen reducing the patients dependence on oxygen supplements.
All those patient’s who were treated with the 2-DG drug showed a conversion of Positive to negative report of COVID-19. In the RT-PCR tests conducted it was observed that the patient RT-PCR report came to be negative. Not only in the conversion of positive to negative but this drug showed some more improvements in the patient. Those patient’s injected with this drug 2-DG were showing a great recovery then reported in Soc ( Standard of Care).
How does the Drug 2-DG works ?
According to report by the DRDO ( Defense Research and Development Organization) the drug when ingested orally. Goes and accumulates in the injected cells and stop the growth of the cells. The stop of the infected growth cells takes place by their inhibition in viral synthesis and energy production.
Higher proportion of patients who were treated with 2-DG . Showed RT-PCR negative conversion in #COVID patients. In efficacy trends, the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints: DRDO told to Ani via Twitter.
It’s proud moment for all of us cause in these high alarming times. Where Remedisever is available to everyone out there. And crisis of Oxygen cylinder and their transportation. This drug nearly helps the patient to improve their oxygen rate.
The team therightmag.com request its readers to wear mask. Stay in home and stay safe.